Renal effects of prolonged sevoflurane anesthesia in Wistar rats;Efectos renales de la anestesia prolongada con sevoflurano en ratas Wistar

Revista Espanola de Anestesiologia y Reanimacion

Volumn 46, Issue 6, 1999, Pages 241-246

  Bermejo Alvarez M A ^a,b   Rodriguez Dinten M J ^a   Reyes, I ^a   Brime Casanueva, J I ^a   Martinez Merino A ^a   Costales, M ^b  

^a HOSPITAL DE CABUEÑES   (Spain)

^b NONE

Author keywords

Anesthetics, inhalational: sevoflurane; Ions: inorganic fluoride; Kidney: nephrotoxicity

Indexed keywords

FLUORIDE; INHALATION ANESTHETIC AGENT; SEVOFLURANE; SODIUM ION; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BODY WEIGHT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIURESIS; DRUG SAFETY; INHALATIONAL DRUG ADMINISTRATION; KIDNEY FUNCTION; KIDNEY PARENCHYMA; NONHUMAN; RAT; SODIUM BLOOD LEVEL; UREA BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; URINE VOLUME;

ANESTHETICS, INHALATION; ANIMALS; BLOOD UREA NITROGEN; DIURESIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; FLUORINE; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; KIDNEY GLOMERULUS; KIDNEY TUBULES; MALE; METHYL ETHERS; NATRIURESIS; RATS; RATS, WISTAR; TIME FACTORS;

EID: 0344564121     PISSN: 00349356     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Wallin R, Regan B, Napoli M, Stern I. Sevoflurane: a new inhalational anesthetic agent. Anesth Analg 1975; 54: 758-765.
2. Gilsanz F, Celemín R, Blanc G, Orts MM. Sevoflurano. Rev Esp Anestesiol Reanim 1996; 43: 243-248.
3. Eger EI. New inhaled anesthetics. Anesthesiology 1994; 80: 906-922.
4. Martín-Larrauri R. Farmacocinética del sevoflurano. Act Anest Reanim 1995; 5: 107-111.
5. Coriat P. ¿Se aproximan al concepto de anestésico ideal los nuevos anestésicos inhalatorios? Rev Esp Anestesiol Reanim 1996; 43: 233-234.
6. Mazze RI. The safety of sevoflurane in humans. Anesthesiology 1992; 77: 1.062-1.063.
7. Mazze RI, Coussins MJ, Kosek JG. Dose related methoxyflurane nephrotoxicity in rats: a biochemical and patologic correlation. Anestheslology 1972; 36: 571-587.
8. Kharasch ED, Karol MD, Lanni C, Sawchuk R. Clinical sevoflurane metabolism and disposition (sevoflurane and metabolite pharmacokinetics). Anesthesiology 1995; 82: 1.369-1.378.
9. 2O anaesthesia. Br J Anaesth 1995; 74 (Supl 1): 94.
10. Coussins MJ, Mazze RI. Methoxyflurane nephrotoxicity: a study of dose-response in man. JAMA 1973; 225: 1.611-1.616.
11. Crandell WB, Pappas SG, MacDonald A. Nephrotoxicity associated with methoxyflurane anesthesia. Anesthesiology 1967; 27: 591-607.
12. Higuchi H, Sumikura H, Sumita S, Arimura S, Takamatsu F, Kanno M et al. Renal function in patients with high serum fluoride concentration after prolonged sevoflurane anesthesia. Anesthesiology 1995; 83: 449-458.
13. Malan TP Jr. Sevoflurane and renal function. Anesth Analg 1995; 81 (Supl): 39-45.
14. Kobayashi Y, Ochiai R, Takeda J, Sekiguchi H, Fukushima K. Serum and urinary inorganic fluoride concentrations after prolonged inhalation of sevoflurane in humans. Anesth Analg 1992; 74: 753-757.
15. Frink EJ, Chantons H, Malan TP, Morgan S, Fernando J, Gandolfi J et al. Plasma inorganic fluoride with sevoflurane anesthesia: correlation with indices of hepatic and renal function. Anesth Analg 1992; 74: 231-235.
16. Ebert TJ, Frink EJ, Karash ED. Absence of biochemical evidence for renal and hepatic disfunction after 8 hours of 1,25 minimum alveolar concentration sevoflurane anesthesia in volunteers. Anesthesiology 1998; 88: 601-610.
17. Mazze RI, Jamison R. Renal effects of sevoflurane. Anesthesiology 1995; 83: 443-445.
18. McGrath B, Hodgins L. The effect of sevoflurane vs isoflurane on renal function in patients with renal insufficiency. Anesth Analg 1995; 80: 312.
19. Nuscheler M, Conzen PF, Melotte A, Van Aken H, Peter K. Renal function after sevoflurane vs enflurane anesthesia in patient with renal impairment. Anesthesiology 1994; 81 (Supl): 362.
20. Kharasch ED. Biotransformation of Sevoflurane. Anesth Analg 1995; 81 (Supl): 27-38.
21. Mazze RI. Metabolism of the inhaled anestetics: implications of the enzyme induction. Br J Anaesth 1984; 56: 27-41.
22. Frink EJ, Malan TP, Morgan SE, Brown EA, Malcomsom M, Brown BR. Quantification of the degradation products of sevoflurane in two CO, absorbants during low-flow anesthesia in surgical patients. Anesthesiology 1992; 77: 1.064-1.069.
23. Morio M, Fujii K, Satoh N, Imai M, Kawakami U, Mizuno T et al. Reaction of sevoflurane and its degradation products with soda lime: toxicity of the byproducts. Anesthesiology 1992; 77: 1.155-1.164.
24. Iyer RA, Frink EJ, Ebert TJ, Anders MW. Cysteine conjugate β-Lyase-dependent metabolism of compound A in humans subjects anesthetized with sevoflurane and rats given compound A. Anesthesiology 1998; 88: 611-618.
25. Bito H, Ikeda K. Effect of total flow rate on the concentration of degradation products generated by reaction between sevoflurane and soda lime. Br J Anesth 1995; 74: 667-669.
26. Bito H, Ikeda K. Closed-circuit anesthesia with sevoflurane in humans (effects on renal and hepatic function and concentrations of breakdown products with soda lime in the circuit). Anesthesiology 1994; 80: 71-76.
27. Eger EI, Koblin DD, Bowland T, Ionescu P, Laster MJ, Fang Z et al. Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg 1997; 84: 160-168.
28. Higuchi H, Sumita S, Wada H, Ura T, Ikemoto T, Nakai T et al. Effects of sevoflurane and isoflurane on renal function on possible markers of nephotoxicity. Anesthesiology 1998; 89: 307-322.
29. Cook TL, Beppu WJ, Hitt BA, Kosek JC, Mazze RI. Renal effects and metabolism of sevoflurane in Fisher 344 rats: an "in vivo" and "in vitro" comparison with methoxyflurane. Anesthesiology 1975; 43: 70-77.
30. Goldemberg L. Treatment de la maladie de Basedow et de l'hyperthiroidisme par le fluor. Presse Med 1930; 102: 1.751-1.754.
31. Mazze PI, Hitt BA. Methoxyflurane metabolism. Anesthesiology 1976; 44: 369-371.
32. Cohen PI. Effects of the anesthetics on mitochondrial function. Anesthesiology 1973; 39: 153-164.
33. Mazze RI, Trudell JR, Coussins MJ. Methoxyflurane metabolism and renal disfunction: clinical correlation in man. Anesthesiology 1971; 35: 247-252.
34. Frink EJ, Malan TP, Isner RJ, Brown EA, Morgan SE, Brown BR. Renal concentrating function with prolonged sevoflurane or enflurane anesthesia in volunteers. Anesthesiology 1994; 80: 1.019-1.025.
35. Cook TL, Beppu WJ, Hitt BA, Kosek JC, Mazze RI. A comparison on renal effects and metabolism of sevoflurane and methoxyflurane in enzyme-induced rats. Anesthesiology 1975; 42: 420-424.
36. Bito H, Ikeda K. Plasma inorganic fluoride and intracircuit degradation produts concentration in long-duration, low flow sevoflurane anesthesia. Anesth Analg 1994; 79: 946-951.
37. Kong KL, Tyler JE, Willats SM, Prys-Roberts C. Isoflurane sedation for patients undergoing mechanical ventilation: metabolism to inorganic fluoride and renal effects. Br J Anaesth 1990; 64: 159-162.
38. Levine MF, Sarner J, Lerman J, Davis P, Nikich N, Maloney K et al. Plasma inorganic fluoride concentration after sevoflurane anesthesia in children. Anesthesiology 1996; 84: 348-353.
39. Kharasch ED, Hankins DC, Thummel KE. Human kidney methoxyflurane and sevoflurane metabolism, (Intrarrenal fluoride production as a possible mecanism of methoxyflurane nephrotoxicity). Anesthesiology 1995; 82: 689-699.
40. Kharasch ED, Thummel KE. Identification of cytochrome P 450 2E1 as the predominant enzyme catalyzing human liver microsomal deflurination of sevoflurane, isoflurane and methoxyflurane. Anesthesiology 1993; 79: 795-807.
41. De Waziers I, Cugnenc PH, Yang CS, Leroux JP, Beaune PH. Cytochrome P-450 isoenzymes epoxide hydrolase and gluthatione transferases in rat and human hepatic and extrahepatic tissues. J Pharmacol Exp Ther 1990; 253: 387-394.